Evidence map›Paper›PMID 32293291›Full record

Observational studyBMC gastroenterology2020

Gastroesophageal reflux disease in a typical African population: a symptom-based multicenter study.

Sylvester Chuks Nwokediuko, Olusegun Adekanle, Adegboyega Akere, Abdulfatai Olokoba, Chiedozie Anyanechi, Sabo Mustapha Umar, Abubakar Maiyaki, Uchenna Ijoma, Olive Obienu, Augustine Uhunmwangho and 1 more

Open access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in BMC gastroenterology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 1 country.

Sylvester Chuks NwokediukoDepartment of Medicine, University of Nigeria Teaching Hospital, Ituku Ozalla, Enugu State, Nigeria. Sylvester.nwokediuko@unn.edu.ng.
Olusegun AdekanleDepartment of Medicine, Obafemi Awolowo University Teaching Hospital Complex, Ile-Ife, Osun State, Nigeria.
Adegboyega AkereDepartment of Medicine, University College Hospital, Ibadan, Oyo State, Nigeria.
Abdulfatai OlokobaDepartment of Medicine, University of Ilorin Teaching Hospital, Ilorin, Kwara State, Nigeria.
Chiedozie AnyanechiDepartment of Medicine, Federal Medical Centre, Umuahia, Abia State, Nigeria.
Sabo Mustapha UmarDepartment of Medicine, Abubakar Tafawa Balewa University Teaching Hospital, Bauchi, Bauchi State, Nigeria.
Abubakar MaiyakiDepartment of Medicine, Othman Dan Fodio University Teaching Hospital, Sokoto, Sokoto State, Nigeria.
Uchenna IjomaDepartment of Medicine, University of Nigeria Teaching Hospital, Ituku Ozalla, Enugu State, Nigeria.
Olive ObienuDepartment of Medicine, University of Nigeria Teaching Hospital, Ituku Ozalla, Enugu State, Nigeria.
Augustine UhunmwanghoDepartment of Medicine, University of Abuja Teaching Hospital, Gwagwalada, Nigeria.
Dennis NdububaDepartment of Medicine, Obafemi Awolowo University Teaching Hospital Complex, Ile-Ife, Osun State, Nigeria.
University of Nigeria Teaching Hospital · NGObafemi Awolowo University Teaching Hospitals Complex · NGAbubakar Tafawa Balewa University · NGFederal Medical Centre · NGUniversity College Hospital, Ibadan · NGUniversity of Abuja Teaching Hospital · NGUniversity of Ilorin Teaching Hospital · NGUsmanu Danfodiyo University Teaching Hospital, Sokoto · NG

Funding

AstraZeneca NIGERIA ASTRAZENECA SOUTH AFRICA
6 · The paper itself

Abstract

backgroundThe prevalence of gastroesophageal reflux disease (GERD) in Africa is not known but is believed to be increasing because of demographic and epidemiologic transition. The main objectives of this study were to determine the prevalence and risk factors of GERD, and its degree of overlap with dyspepsia and irritable bowel syndrome (IBS) in Nigeria, a typical African population.

methodsThis was an observational, cross-sectional and descriptive study of adult Nigerians. Diagnosis of GERD was by means of the gastroesophageal reflux disease questionnaire (GERDQ) while the diagnosis of dyspepsia and IBS was based on the Rome III criteria for the diagnosis of functional gastrointestinal disorders. The GERDQ and Rome III questionnaires for dyspepsia and IBS were merged into a composite questionnaire and administered to the study participants who were recruited with a multi-stage sampling technique.

resultsOut of 3520 subjects who participated in the study across the country, 269 (7.6%) satisfied the diagnostic criteria for GERD, while 107 (3.0%) had GERD associated with significant impairment of quality of life. Risk factors of GERD (represented by odds ratios) were age 1.014(95% CI: 1.006-1.022), use of analgesics 1.461 (95% CI: 1.060-2.025), and use of herbs 1.318 (95% CI: 1.020-1.704). Overlap of GERD with dyspepsia and/or IBS was observed in over 50% of cases.

conclusionsThe prevalence of GERD in this study is 7.6%. Age, use of analgesics and use of herbs increase the risk, albeit minimally. A high degree of overlap with dyspepsia and IBS exists in Nigerian patients with GERD.

Indexed as

AdultAgedComorbidityCross-Sectional StudiesDyspepsiaFemaleGastroesophageal RefluxHumansIrritable Bowel SyndromeMaleMiddle AgedNigeriaPrevalenceRisk FactorsAfricaGERDNigeria

Identifiers

PMID32293291
PMCPMC7157995
OpenAlexW3015403298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.